In Filariasis Filariasis is a disease caused by parasites that infect the human body through the opening created by mosquito bites. It causes abnormal enlargement of body parts (especially lower part of the body), pain and difficulty in carrying out daily life activities. Along with this, the associated social stigma and discrimination hampers the social lives of peple who suffer from filariasis. Esnocof XP Syrup helps treat filariasis as well as prevents the further spread of the infection. This helps improve your social life and makes you gain back your confidence too. Keep taking it as advised by the doctor to get the maximum benefit.
Esnocof XP Syrup may cause excessive drowsiness with alcohol.
Information regarding the use of Esnocof XP Syrup during pregnancy is not available. Please consult your doctor.
Information regarding the use of Esnocof XP Syrup during breastfeeding is not available. Please consult your doctor.
Esnocof XP Syrup may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Esnocof XP Syrup should be used with caution in patients with kidney disease. Dose adjustment of Esnocof XP Syrup may be needed. Please consult your doctor. Not recommended in patients with severe kidney disease. May cause excessive sleepiness in patients with end stage kidney disease.
Esnocof XP Syrup is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Esnocof XP Syrup may not be needed in these patients. Please consult your doctor.
If you miss a dose of Esnocof XP Syrup, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Biomedica Life Science || ₹14.5/tablet (25% cheaper)